ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy.

Fei Shu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.